Carroll, Paul, Waddell, Simon J, Butcher, Philip D and Parish, Tanya (2011) Methionine sulfoximine resistance in Mycobacterium tuberculosis is due to a single nucleotide deletion resulting in increased expression of the major glutamine synthetase, GlnA1. Microbial Drug Resistance, 17 (3). pp. 351-355. ISSN 1076-6294

PDF - Published Version Download (248kB)

Abstract

We investigated the effect of methionine sulfoximine (MetSox), a potent inhibitor of glutamine synthetase, on Mycobacterium tuberculosis. M. tuberculosis encodes four glutamine synthetases, of which MetSox targets the type I enzyme encoded by glnA1. Trancriptional profiling revealed that glutamate synthetase (gltB) and a type II glutamine synthetase (glnA3) were induced after exposure to MetSox. In addition, we observed a high rate (10−5) of spontaneous resistance to MetSox. All resistant strains had a single-nucleotide deletion in the 5’ region of glnA1, and Western analysis revealed that GlnA1 expression was increased in resistant as compared with sensitive strains. These data show that M. tuberculosis can respond to the effect of MetSox inhibition either by up-regulation of GlnA3 or by GlnA1. The high frequency of resistance suggests that MetSox and other compounds specifically targeting GlnA1 are not likely to become successful anti-mycobacterial agents.

Item Type:	Article
Schools and Departments:	Brighton and Sussex Medical School > Clinical and Experimental Medicine Brighton and Sussex Medical School > Global Health and Infection
Subjects:	Q Science > QH Natural history > QH0301 Biology R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Depositing User:	Grecia GarciaGarcia
Date Deposited:	12 Apr 2012 11:29
Last Modified:	02 Jul 2019 18:04
URI:	http://sro.sussex.ac.uk/id/eprint/7284

View download statistics for this item

📧 Request an update